Patents by Inventor Stephen M. Carl

Stephen M. Carl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceuticals for Oral Delivery
    Publication number: 20170319502
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Application
    Filed: July 21, 2017
    Publication date: November 9, 2017
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for oral delivery
    Patent number: 9744140
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: August 29, 2017
    Assignee: Enteris Biopharma, Inc.
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for Oral Delivery
    Publication number: 20170056328
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Application
    Filed: November 16, 2016
    Publication date: March 2, 2017
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for oral delivery
    Patent number: 9526785
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: December 27, 2016
    Assignee: ENTERIS BIOPHARMA, INC.
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for Oral Delivery
    Publication number: 20160296624
    Abstract: The present invention provides pharmaceutical compositions suitable for oral delivery and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 13, 2016
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for oral delivery
    Patent number: 9457086
    Abstract: The present invention provides solid oral dosage forms and methods of treating subjects in need thereof. The solid oral dosage forms of the present invention provide a mixture including at least one compound classified as BCS Class II, BCS Class III or BCS Class IV, where the compound does not include a peptide bond in the compound's molecular structure; an absorption enhancer; and coated organic acid particles; an enteric coating; and a water soluble barrier positioned between the mixture and the enteric coating.
    Type: Grant
    Filed: March 5, 2014
    Date of Patent: October 4, 2016
    Assignee: Enteris BioPharma, Inc.
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern
  • Pharmaceuticals for Oral Delivery
    Publication number: 20140255479
    Abstract: The present invention provides pharmaceutical compositions suitable for oral and methods of treating subjects in need thereof. The pharmaceutical compositions of the present invention enhance bioavailability of at least one compound classified as BCS Class II, BCS Class III or BCS Class IV.
    Type: Application
    Filed: March 5, 2014
    Publication date: September 11, 2014
    Inventors: Stephen M. Carl, John Stanley Vrettos, William Stern